Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Bone Formation by Endochondral Ossification

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Autologous platelet rich gel in treatment of lower limb atherosclerotic occlusive disease in diabetic patients.

World journal of diabetes·2025

Same author

Elevated KIF2C Expression Drives Osteosarcoma Progression by Modulating the Wnt/β-Catenin Signaling Pathway and Contributing to an Immunosuppressive Tumor Microenvironment.

Cancer medicine·2025

Same author

Clinical application of multiple 3D-printed guide plates for precise reduction and fixation of comminuted patellar fractures.

The Journal of international medical research·2020

Same author

Bone repair scaffold coated with bone morphogenetic protein-2 for bone regeneration in murine calvarial defect model: Systematic review and quality evaluation.

The International journal of artificial organs·2019

Same author

Scaffolds for the repair of bone defects in clinical studies: a systematic review.

Journal of orthopaedic surgery and research·2018

Same author

Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population.

Molecular carcinogenesis·2013

Same journal

Association of the PD-L1 CPS With the Efficacy of First-Line Nivolumab Plus Chemotherapy for Unresectable Advanced or Recurrent Gastric Cancer.

Cancer medicine·2026

Same journal

Fear of Cancer Recurrence and Coping in Young Breast Cancer Survivors: A Secondary Analysis.

Cancer medicine·2026

Same journal

Correction to "Radiotherapy and Cardiovascular Disease Survival Risk in Non-Small Cell Lung Cancer: A Population-Based Study From the Surveillance, Epidemiology, and End Results Database".

Cancer medicine·2026

Same journal

Assessing Financial Toxicity in Cancer: A Global Systematic Review and Meta-Analysis Using an Asset Framework.

Cancer medicine·2026

Same journal

Years of Life Lost of Patients With Early Adenocarcinoma of the Esophagogastric Junction Compared to Esophageal or Gastric Adenocarcinoma. A Registry-Based Study.

Cancer medicine·2026

Same journal

Elevation of Eosinophil Proportion After Pembrolizumab Increases the Risk of Immune-Related Adverse Events in Patients With Bladder Cancer.

Cancer medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 23, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

FAM60A promotes osteosarcoma development and progression.

Yu Sun¹, Yu-Nan Man¹, Jin-Hui Cheng²

¹Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P.R. China.

Cancer Medicine

|July 13, 2023

Summary

This summary is machine-generated.

Family of Homology 60A (FAM60A) is upregulated in osteosarcoma (OS), promoting tumor cell proliferation and inhibiting apoptosis. This study highlights FAM60A as a potential therapeutic target for osteosarcoma.

Keywords:

clinical significance family of homology 60A hub genes osteosarcoma

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Related Experiment Videos

Last Updated: Jul 23, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Osteosarcoma (OS) is a highly malignant primary bone tumor.
Family of Homology 60A (FAM60A) is implicated in the progression of various cancers.

Purpose of the Study:

To investigate the role of FAM60A in osteosarcoma.
To analyze FAM60A expression and its correlation with prognosis in OS patients.

Main Methods:

Analysis of FAM60A mRNA and protein expression in OS tissues and cell lines using public databases, immunohistochemistry, RT-qPCR, and Western blotting.
Functional assays including CCK-8, colony formation, and flow cytometry to assess the impact of FAM60A knockdown on OS cells.
Gene enrichment analysis to identify FAM60A co-expressed genes and potential regulatory pathways.

Main Results:

FAM60A mRNA and protein levels were significantly upregulated in osteosarcoma.
Higher FAM60A expression correlated with poor prognosis in OS patients.
FAM60A knockdown inhibited OS cell proliferation, induced apoptosis, and arrested cells in the S phase, implicating cell cycle regulation.

Conclusions:

FAM60A is markedly upregulated in osteosarcoma and promotes tumor cell proliferation while inhibiting apoptosis.
FAM60A plays a role in cell cycle regulation and may interact with hub genes (BUB1, DTL, EXO1) in OS progression.